Influence of the number of high-risk cytogenetic abnormalities on the clinical characteristics and prognosis in 360 patients with newly diagnosed multiple myeloma

被引:0
|
作者
陈智 [1 ]
机构
[1] Dept Hematol,1st Affil Hosp,Nanjing Med Univ
关键词
D O I
暂无
中图分类号
R733.3 [骨髓肿瘤];
学科分类号
摘要
Objective To investigate the influence of the number of high-risk cytogenetic abnormalities (HRCA)on the clinical characteristics and prognosis of patients with newly diagnosed multiple myeloma (MM).Methods A total of 360 patients with newly diagnosed MM admitted to Jiangsu Province Hospital between November 2013 and September 2020 were included in this study. Cytoplasmic light chain immunofluorescence with fluorescence in situ hybridization (cIg-FISH) was used to detect HRCA. Cytogenetic abnormalities were combined with clinical characteristics and outcomes for further analysis. Results Among the 360 patients,120patients (33.3%) didn’t present with HRCAs,and 175(48.6%),61 (16.9%),and four (1.1%) patients had one, two, and three HRCA (s), respectively.
引用
收藏
页码:182 / 183
页数:2
相关论文
共 50 条
  • [41] Experimental Characteristics of Patients with Newly Diagnosed Multiple Myeloma
    Li, Linzhang
    Han, Chengwu
    Yu, Xueying
    Cai, Ying
    Cao, Yongyue
    Shen, Jun
    Cao, Yongtong
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (08) : 529 - 533
  • [42] Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
    Leypoldt, Lisa B.
    Tichy, Diana
    Besemer, Britta
    Haenel, Mathias
    Raab, Marc S.
    Mann, Christoph
    Munder, Markus
    Reinhardt, Hans Christian
    Nogai, Axel
    Goerner, Martin
    Ko, Yon-Dschun
    de Wit, Maike
    Salwender, Hans
    Scheid, Christof
    Graeven, Ullrich
    Peceny, Rudolf
    Staib, Peter
    Dieing, Annette
    Einsele, Hermann
    Jauch, Anna
    Hundemer, Michael
    Zago, Manola
    Pozek, Ema
    Benner, Axel
    Bokemeyer, Carsten
    Goldschmidt, Hartmut
    Weisel, Katja C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 26 - +
  • [43] NUMBER OF ADVERSE CYTOGENETIC LESIONS DETECTED BY FISH IS ASSOCIATED WITH PROGNOSIS IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-BASED REGIMENS
    Grzasko, N.
    Hus, M.
    Morawska, M.
    Chocholska, S.
    Jurczyszyn, A.
    Hajek, R.
    Wojciechowicz, J.
    Kostyra, M.
    Dmoszynska, A.
    HAEMATOLOGICA, 2013, 98 : 338 - 338
  • [44] Correlation between Clinical Factors and Prognosis in Newly Diagnosed Multiple Myeloma
    Zhao, Xiao-Qing
    Zhao, Shu-Ying
    Chen, Wen-Xin
    Liu, Xiao-Wei
    Yan, Huai-Xiu
    Lou, Yong-Ji
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (06): : 601 - 605
  • [45] Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities
    Guman, Tomas
    Sykora, Jan
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (01): : 9 - 11
  • [46] Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma
    Liang, Xinyue
    Xu, Weiling
    Zhou, Fan
    Huang, Wenyang
    Yi, Xingcheng
    Zhang, Yingjie
    Yan, Yurong
    Zhang, Nan
    Wang, Jingxuan
    Sun, Xiaoxiao
    Hu, Rui
    Zhu, Yufeng
    Ma, Xintian
    Sun, Yue
    Lan, Maozhou
    Long, Mengtuan
    Kumar, Shaji K.
    Dai, Yun
    Jin, Fengyan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2025, 15 (02):
  • [47] A High-Risk Multiple Myeloma Group Identified By Integrative Multi-Omics Segmentation of Newly Diagnosed Patients
    Ortiz, Maria
    Towfic, Fadi
    Samur, Mehmet Kemal
    Flynt, Erin
    Jang, In Sock
    Wang, Kai
    Ashby, Cody
    Walker, Brian A.
    Trotter, Matthew
    Morgan, Gareth
    Munshi, Nikhil
    Thakurta, Anjan
    BLOOD, 2018, 132
  • [48] Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities
    Abdallah, Nadine
    Greipp, Patricia
    Kapoor, Prashant
    Gertz, Morie A.
    Dispenzieri, Angela
    Baughn, Linda B.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dingli, David
    Go, Ronald S.
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam
    Lin, Yi
    Leung, Nelson
    Kourelis, Taxiarchis
    Warsame, Rahma
    Siddiqui, Mustaqeem
    Lust, John
    Kyle, Robert A.
    Bergsagel, Leif
    Ketterling, Rhett
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD ADVANCES, 2020, 4 (15) : 3509 - 3519
  • [49] Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma
    Ng, Alvin C.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Drake, Matthew T.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (07) : 397 - 400
  • [50] Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)
    Kim, Kihyun
    Kim, Jin Seok
    Yoon, Sung-Soo
    Yoon, Dok Hyun
    Eom, Hyeon-Seok
    Lee, Je-Jung
    Yim, Hyeon Woo
    Park, Misun
    Lee, Hojoon
    Min, Chang-Ki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (01) : 110 - 121